A comparative clinical study of Dhatrilauha with Draksha ghrita and Iron folic acid tablets in the management of deficiency of Haemoglobin in blood during Pregnancy.

A RANDOMIZED CONTROL CLINICAL TRIAL OF DHATRILAUHA WITH DRAKSHAGHRITA AND IRON FOLIC ACID TABLETS IN THE MANAGEMENT OF GARBHINIPANDU

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018731

Enrollment

100

Registered

2019-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D508- Other iron deficiency anemias

Interventions

Intervention1: DHATRILAUHA WITH DRAKSHAGHRITA: DHATRILAUHA 1 GRAM WITH DRAKSHAGHRITA 10 GRAMS, TWICE A DAY, IN BETWEEN TWO MEAL WITH LUKEWARM WATER FOR 60 DAYS Control Intervention1: IRON FOLIC ACID

Eligibility

Inclusion criteria

Inclusion criteria: 1. A pregnant woman aged between 20-35 years. 2. Pregnant woman with haemoglobin percentage 7.0-10.00 gm/dl (moderate Anaemia), haematocrit less than 33% in order to study the drug effect to maintain haemoglobin percentage. 3. A pregnant woman with anaemia between 13th to 28th weeks of pregnancy.

Exclusion criteria

Exclusion criteria: 1. Anaemia other than iron deficiency Anaemia. 2. Patients having haemoglobin percentage less than 7.0 gm/dl. and more than 10.0 gm/dl 3. Patients suffering from systemic diseases like Hypertension, Diabetes, Thyroid disorders, Liver disorders, Renal disorder, Cardio Vascular disorders, Cerebro-Vascular disorders, Tuberculosis etc. 4. Patients suffering from pregnancy related complications such as Pregnancy induced hypertension (PIH), Pre-eclampsia, Eclampsia, Hyperemesis gravidarum, Gestational diabetes etc. 5. Pregnancy associated with Rh Incompatibility, Jaundice, Ovarian tumour, Placenta previa, Abruptio placenta.

Design outcomes

Primary

Measure	Time frame
EFFECT OF DHATRILAUHA WITH DRAKSHA GHRITA ON HEMATOLOGICAL PARAMETERSTimepoint: 60 DAYS	—

Secondary

Measure	Time frame
To compare the effect of Iron folic acid tablets and Dhatrilauha with Drakshaghrita on haematological parametersTimepoint: 60 DAYS	—

Countries

India

Contacts

Public ContactSANDHYA RAV

NATIONAL INSTITUTE OF AYURVEDA

baruhunt@gmail.com9492047131

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026